United States · FDA National Drug Code directory
DERMOSCRIBE SEBORRHEIC DERMATITIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69683-202_4161aee0-5f36-1739-e063-6294a90a5bdf
- Product NDC
- 69683-202
- Form
- CREAM
- Composition / generic term
- SULFUR, SALICYLIC ACID, HYDROCORTISONE
- Labeler
- DERMOSCRIBE PTY LTD
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20150323
- Source listing expiry
- 20261231
Source-listed ingredients
- SULFUR — 3 g/100g
- SALICYLIC ACID — 3 g/100g
- HYDROCORTISONE — 1 g/100g
These values do not establish equivalence or a dose recommendation.
Packages
- 60 g in 1 BOTTLE (69683-202-11) · 69683-202-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →